Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome

被引：51

作者：

Bain, Barbara J. ^{[1
]}

Fletcher, Sarah H. ^{[1
]}

机构：

[1] St Marys Hosp, Imperial Coll Fac med, Dept Haematol, London W2 1NY, England

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2007年 / 27卷 / 03期

关键词：

D O I：

10.1016/j.iac.2007.06.001

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Among patients with hypereosinophilia, a myeloproliferative variant is recognized. In many of these patients a diagnosis of eosinophilic leukemia can be made. The molecular mechanism is often a fusion gene, incorporating part of PDGFRA or PDGFRB, encoding anaberrant tyrosine kinase. Prompt diagnosis of such cases is important since specific tyrosine kinase inhibitor therapy is indicated.

引用

页码：377 / +

页数：13

共 57 条

[11]

Curtis C, 2005, BLOOD, V106, p909A

[12] Imatinib mesylate responsiveness in aggressive systemic mastocytosis:: Novel association with a platelet derived growth factor receptor beta mutation [J].

Dalal, Bakul I. ;

Horsman, Douglas E. ;

Bruyere, Helene ;

Forrest, Donna L. .

AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (01) :77-79

[13] Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders [J].

David, Marianna ;

Cross, Nicholas C. P. ;

Burgstaller, Sonja ;

Chase, Andrew ;

Curtis, Claire ;

Dang, Raymond ;

Gardembas, Martine ;

Goldman, John M. ;

Grand, Francis ;

Hughes, George ;

Huguet, Francoise ;

Lavender, Louise ;

McArthur, Grant A. ;

Mahon, Francois X. ;

Massimini, Giorgio ;

Melo, Junia ;

Rousselot, Philippe ;

Russell-Jones, Robin J. ;

Seymour, John F. ;

Smith, Graeme ;

Stark, Alastair ;

Waghorn, Katherine ;

Nikolova, Zariana ;

Apperley, Jane F. .

BLOOD, 2007, 109 (01) :61-64

[14] Eosinophilia and granulocytic dysplasia terminating in acute myeloid leukaemia after 24 years [J].

Doorduijn, JK ;

VanLom, K ;

Lowenberg, B .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (03) :531-534

[15] Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder:: The first fusion gene involving BCR but not ABL [J].

Fioretos, T ;

Panagopoulos, I ;

Lassen, C ;

Swedin, A ;

Billström, R ;

Isaksson, M ;

Strömbeck, B ;

Olofsson, T ;

Mitelman, F ;

Johansson, B .

GENES CHROMOSOMES & CANCER, 2001, 32 (04) :302-310

[16]

GAVRILESCU LC, 2006, BLOOD, V108, P3634

[17] FUSION OF PDGF RECEPTOR-BETA TO A NOVEL ETS-LIKE GENE, TEL, IN CHRONIC MYELOMONOCYTIC LEUKEMIA WITH T(512) CHROMOSOMAL TRANSLOCATION [J].

GOLUB, TR ;

BARKER, GF ;

LOVETT, M ;

GILLILAND, DG .

CELL, 1994, 77 (02) :307-316

[18] Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome [J].

Grand, EK ;

Grand, FH ;

Chase, AJ ;

Ross, FM ;

Corcoran, MM ;

Oscier, DG ;

Cross, NCP .

GENES CHROMOSOMES & CANCER, 2004, 40 (01) :78-83

[19] p53-binding protein 1 is fused to the platelet-derived growth factor receptor β in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder [J].

Grand, FH ;

Burgstaller, S ;

Kühr, T ;

Baxter, EJ ;

Webersinke, G ;

Thaler, J ;

Chase, AJ ;

Cross, NCP .

CANCER RESEARCH, 2004, 64 (20) :7216-7219

[20] FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33) [J].

Guasch, G ;

Mack, GJ ;

Popovici, C ;

Dastugue, N ;

Birnbaum, D ;

Rattner, JB ;

Pébusque, MJ .

BLOOD, 2000, 95 (05) :1788-1796

← 1 2 3 4 5 6 →